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Background: Statins are generally well tolerated and effective at reducing a patient’s risk 
of both primary and secondary cardiovascular events. Many patients who would benefit from 
statin therapy either do not adhere to or stop taking their statin medication within the first year. 
We developed an audio booklet targeted to low health literacy patients to teach them about the 
benefits and risks of statins to help the patients adhere to their statin therapy.
Methods: Through focus groups and an iterative design, an audio booklet was developed for 
both English-speaking and Spanish-speaking patients. We then compared the booklet with 
standard of care in 132 patients from our target patient population to measure its impact on 
knowledge and understanding of statins.
Results: The patients enjoyed the audio booklet and showed significant increases in knowl-
edge after listening to it when compared with those who received the standard of care 
materials.
Conclusion: The audio booklet shows promise as a tool that can be used effectively in clinical 
practice to teach patients about statin therapy.
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Introduction
Coronary heart disease continues to be the leading cause of death in the US. HMG-CoA 
reductase inhibitors (statins) reduce the risk of heart attack and stroke by 30%–40%.1 
Statin therapy has shown a very low incidence of harm.2 Despite their demonstrated 
efficacy and safety, the acceptance, persistence, and adherence rates with statins are 
below 50%.3–9 Many patients who start taking medication to lower cholesterol and 
reduce their risk for heart attack and coronary death, stop taking it; and 30%–50% of 
patients take self-initiated “drug holidays.”10 A majority of patients who start statin 
therapy stop it within the first year.11 A vast amount of literature exists on improving 
adherence to chronic medication, but interventions to improve adherence to chronic 
medications have seldom produced impressive results.12–14 Therefore, more effective 
interventions are needed. As the increased disease burden and the economics surround-
ing lack of adherence to statin medications becomes better understood, the need for 
these   interventions become more acute.
To varying degrees, dyslipidemia affects every patient population. One of the more 
difficult populations to educate about statin therapy is the low health literacy patient 
population. Health literacy is defined by the Institute of Medicine as the degree to which 
individuals have the capacity to obtain, process, and understand basic health informa-
tion and services needed to make appropriate health decisions.15 Individuals with low Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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health literacy have poorer health outcomes and are more 
likely to be poor, medically underserved, and/or of minority 
ethnicity.16–18 These issues are even more pronounced for 
immigrants. In our patient population, over half the patients 
only speak Spanish.
Given that many of the patients in this vulnerable popu-
lation have poor reading skills and difficulty understanding 
health-related information, we developed an educational 
audio booklet that addresses the most common questions and 
concerns that patients have about taking statin medications 
to reduce their risk for cardiovascular events. The audio 
booklet is not a patient decision aid, rather it is targeted to 
patients who have been prescribed statin medications and is 
meant to address their questions and concerns about taking 
statin therapy. We intentionally designed the intervention 
for patients with poor to no reading skills. The purpose of 
this study was to determine the feasibility of the use of an 
audio booklet in a community health clinical setting with 
patients from the target patient population. The program was 
developed both in English and Spanish to address the needs 
of the target population.
Methods
Theoretical framework
The Extended Parallel Process Model (EPPM) served as the 
framework for developing the health messages in the audio 
booklet intervention. While drawing concepts from fear appeal 
theories, the EPPM presents a broader view of responses to 
health messages as being both positive and   negative.19 Health 
messages are seen as involving two   cognitive components, ie, 
an appraisal of threat and an appraisal of efficacy related to 
the recommended response or behavior. The threat appraisal 
involves perceptions of personal susceptibility to the threat 
(ie, “it can happen to me”) and perceived severity (ie, “it is 
a serious concern”). People who have low perceived sus-
ceptibility or severity will likely ignore the health message. 
Perceived efficacy appraisal is characterized by perceptions of 
self-efficacy (ie, “I can engage in the recommended behavior”) 
and response efficacy (ie, “if I engage in the recommended 
behavior, it will benefit me”). People who perceive low self-
efficacy and response efficacy are likely to develop a defensive 
motivation and reject the message. This describes the fear 
control process. People who perceive high self-efficacy and 
response efficacy develop a protective motivation and accept 
the message. This describes the danger control process in the 
EPPM.19
The EPPM has direct implications for the design of health 
messages, including messages about statin medications. 
Patients with hyperlipidemia who have been prescribed a 
statin medication need to understand that they are at increased 
risk of heart attack and stroke and that these are serious 
concerns. Furthermore, they need to learn about taking the 
medication and its potential harms, and that by taking the 
medication they can lower their risk.
Development of the intervention
For baseline knowledge, structured interviews were con-
ducted with patients from the target patient population in 
the Harris County Hospital District. After formal review 
and approval by the institutional review board, patients were 
recruited using fliers in the target clinics. Eighteen inter-
views were conducted (nine Hispanic patients [six Spanish 
  speakers] and nine non-Hispanic English speakers) with 
patients taking statin medications to explore their beliefs, 
expectations, and attitudes about treating high cholesterol 
and statins in particular. Eligible patients were 35–75 years 
of age. The research team coded the interviews by using 
the standard methodologies in Atlas.ti software (Berlin, 
Germany). Based upon the data, an audio booklet design 
format was selected because patients indicated that it is a 
favorable way to receive information. Additionally the for-
mat combines visual components (bulleted text, graphics, 
and engaging illustrations) with accompanying narration to 
aid patients with poor reading skills and limited ability to 
understand health-related information.
The flow of the program contains five distinct audio-only 
components. In the first component, a community physician 
describes the basic factual information about cholesterol, where 
it comes from, and how it can affect a person’s health. Next a 
testimonial describes why a person who has high cholesterol, 
but who has not had any cerebrovascular events, decided to 
take statins, and how they handled a potential adverse reaction 
to them. Next, the community physician returns to discuss 
statin medications, their role in prevention, and reasons why a 
patient may want to take a medication even if they do not feel 
any different before or after taking them. A pictograph is used 
to provide a visual representation of the incremental benefit of 
taking a statin on reducing heart attack and stroke. Following that, 
another testimonial is presented about a patient with a previous 
cardiovascular event and appropriate for secondary prevention, 
where she relates her story as to why she takes the medication. 
  Pictures of the persons giving the testimonials appear in the audio 
booklet. The reading level using the Flesch-Kincaid method was 
third grade and had a Flesch Reading Ease score of 81. The audio 
booklet concludes with a discussion of the potential side effects of 
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and how to manage them. The English language version of the 
narration was 10   minutes in length, and the Spanish version was 
11 minutes in length. A printed booklet accompanies the audio 
program to   provide visual reinforcement of the audio and only 
contains the highlights (ie, bulleted text) of the audio. Addition-
ally, the   Spanish translation was back translated to English to 
make sure the message was consistent (see Figure 1 for sample 
pages from the audio booklet).
subjects and setting
Eligible subjects were primary care patients who had been 
told by their primary care provider that they had high 
  cholesterol and were prescribed a statin medication or 
had any prescription refilled within the past three months, 
35–75 years of age, and English or Spanish speakers. Patients 
were excluded if they were blind, did not speak English or 
Spanish, were too ill to participate, or if they refused to enter 
the study. Subjects were recruited from patients presenting 
for care at community health centers operated by the Harris 
County Hospital District. The Baylor College of Medicine 
institutional review board and the Harris County Hospital 
District research office approved the project to be undertaken 
in human subjects.
Procedures
Patients with scheduled appointments were prescreened 
through electronic medical records for eligibility, and then 
approached by study personnel at the time the patient presented 
at the clinical center. For interested patients, eligibility was 
reassessed by patient self-report and they then were consented 
to participate in the study. A randomization block design was 
used to allocate patients to intervention and control groups, and 
accrual continued until 66 African American and 66 Hispanic 
patients had been randomized. Research staff were blinded to 
the patient’s assigned group until the envelope containing the 
randomization sequence was opened after obtaining informed 
consent and prior to completing the demographic questions.
Each patient completed the Short Test of Functional 
Health Literacy in Adults20 before beginning the interviews. 
The study measures were administered via interview and 
collected at the study clinical sites. The preintervention 
  interview included demographic questions, a knowledge 
  measure, and a measure of EPPM constructs. Patients 
assigned to the intervention arm then completed the audio 
booklet; control group patients received the HCHD stan-
dard patient educational brochure on cholesterol and statin 
medications. The postintervention interview included the 
Figure 1 sample pages from the audio booklet.
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  knowledge measure, and EPPM indicators. The audio 
booklet patients were asked questions about acceptability of 
the device immediately after completing the postintervention 
interview.
Measures
Cholesterol and statin medication knowledge was assessed 
using a 15-item measure developed for this study to reflect 
the factual information included in the audio booklet and 
the standard material already used in the clinic. The items 
were written as statements with “true,” “false,” or “don’t 
know” response options. The Risk Behavioral Diagnosis 
Scale was used to measure four key concepts from the 
EPPM, ie, response efficacy, self-efficacy, susceptibility, 
and severity.19 The Risk Behavioral Diagnosis Scale has 
demonstrated adequate internal consistency, reliability 
(alpha coefficients .0.70), and confirmatory factor analy-
sis supports the four-dimension structure of the measure 
reflecting the key concepts from the EPPM.19 The 12-item 
measure was adapted for statin medication to prevent heart 
attack and stroke, as is recommended by the developer. The 
measure uses a seven-point scale, ranging from “strongly 
disagree” to “strongly agree.” Self-rated overall health was 
assessed with a single item, with response options “excel-
lent,” “very good,” “good,” “fair,” and “poor.” Finally, 
patients who received the audio booklet were asked to 
rate its acceptability using questions previously used to 
assess audio booklets.21 Both patient and assessor knew if 
the patient received the standard reading materials or the 
audio booklet.
Analysis
Comparisons of patient characteristics between treatment 
groups were performed using two-sample t-tests for con-
tinuous variables and Pearson χ2 tests or Fisher’s Exact 
tests for categorical variables for the African American 
and Hispanic ethnic groups separately. The groups were 
analyzed separately because they were markedly different in 
their baseline characteristics. Changes in statin knowledge 
score from pretest between treatments were analyzed using 
two-sample t-tests for each ethnicity group. Comparisons 
of the percentages of correct answer for each statin knowl-
edge question between pretest and post-test were performed 
using McNemar’s test by treatments and ethnic groups. All 
tests were two-sided. A P value #0.05 was considered to 
indicate statistical significance. All statistical analyses were 
performed with SAS software, version 9.1 (SAS Institute 
Inc, Cary, NC).
Results
sample characteristics
Sixty-six African American and 66 Hispanic (Spanish-
speaking) patients were randomized. Attrition was 4% and 
was solely due to patients needing to leave the assessments 
before completion. Characteristics of the patients in the study 
are given in Table 1. Among Hispanic patients, over 80% 
indicated Spanish as their primary language, over 80% had 
less than 12 years of education, and most were born outside 
of the US. Patients had been taking statins for an average 
of 2.8–4.3 years. Over half of the patients (53.6%–66.7%) 
indicated that they took their statin medication every day in 
the past week, while others forgot to take their medication 
on at least one day. Over half of the patients (53.6%–67.9%) 
indicated their overall health was fair to poor. Among 
  African American patients, marital status differed between 
the groups; 9.7% assigned to the audio booklet intervention 
were currently married or living with a partner compared with 
34.5% of patients assigned to the standard of care interven-
tion. As expected, the majority of patients were of marginal 
or inadequate health literacy as measured by the Short Test 
of Functional Health Literacy in Adults.
Acceptability of audio booklet
Both African American and Hispanic patients rated the audio 
booklet favorably. All listened to the entire recording, and 
only three did not read along. Over 90% of patients reported 
the length of the audio booklet was about right (the remainder 
indicated the audio booklet was too short), the information 
was clear, they could relate to the stories, they believed the 
people, and felt the stories could happen to them. While 
over 90% of subjects indicated they liked using the audio 
booklet while at the clinic, over 80% had not received similar 
materials at a clinic in the past. There were some differences 
between the patient groups, ie, the Hispanic patients rated 
the booklet design and sound quality slightly higher than did 
the African American patients.
Patient knowledge
At the pretest, Hispanic patients who received the audio 
booklet had the lowest overall baseline knowledge scores 
(see Table 2). Significant improvement in knowledge of 
statins was observed for African American and Hispanic 
patients who received the audio booklet compared with those 
who received standard of care.
At the individual knowledge item level, African   American 
and Hispanic patients assigned to the audio booklet improved 
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a statin. No improvements for this item were observed among 
patients assigned to standard of care. At the post-test, 64% 
of Hispanic and 86% of African American patients knew 
that they should not stop taking a statin after cholesterol 
levels improve.
Improvements in knowledge related to several areas 
of misinformation were also observed. Differences were 
observed for all patients regarding recognition that a skin rash 
was not a side effect of taking a statin, and African American 
patients who received the audio booklet showed a significant 
improvement regarding the recommendation to have liver 
enzymes checked by a doctor when taking a statin.
concepts from the risk Behavioral 
Diagnosis scale
No differences from the pretest to post-test were observed 
for the measure of response efficacy, self-efficacy, personal 
susceptibility, and severity of the condition. There was a 
ceiling effect in that most mean scores at the pretest were 
above 6.0 on the seven-point scale.
Discussion
This feasibility study demonstrated that patients with low 
health literacy who have been prescribed a statin medica-
tion for hyperlipidemia could benefit from an educational 
intervention targeting their use of these medications. 
Patients who were provided with the booklet universally 
reported that they enjoyed the format, and found the 
information useful.   African American patients had a fair level 
of knowledge about high cholesterol and statin therapy, while 
Hispanic patients in the intervention group had the lowest pre 
  intervention knowledge. Regardless of their pre intervention 
knowledge, both groups in the intervention groups experi-
enced a greater increase in knowledge about high cholesterol 
and statin therapy than their standard of care counterparts. 
Future   studies will need to examine if this impacts patient 
  adherence to statin regimes.
No other studies have examined the use of an audio book-
let to improve statin knowledge. A study that examined the 
use of a tailored booklet about statin therapy was superior to 
a booklet about cholesterol in general. Patients who received 
Table 1 Characteristics of the sample, stratified for African American and Hispanic patients
African American patients Hispanic patients
Audio booklet  
(n = 31)
Standard of care  
(n = 29)
P value Audio booklet  
(n = 28)
Standard of care  
(n = 28)
P value
Age (mean [sD]) 57.6 (6.5) 55.6 (8.3) 0.30 57.3 (8.4) 55.3 (7.9) 0.37
Female gender (n [%]) 20 (64.5) 20 (69.0) 0.71 19 (67.9) 20 (71.4) 0.77
education ,12 years (n [%]) 7 (22.6) 8 (27.6) 0.65 23 (82.1) 23 (82.1) 1.00
Born in Us (n [%]) 26 (83.9) 24 (82.8) 1.0 7 (25.0) 3 (10.7) 0.16
Marital status (n [%])
  Divorced/separated 11 (35.5) 5 (17.2) 0.02 4 (14.3) 3 (10.7) 0.41
  Married/Living with partner 3 (9.7) 10 (34.5) 20 (71.4) 16 (57.1)
  single 11 (35.5) 13 (44.8) 3 (10.7) 5 (17.9)
  Widowed 6 (19.4) 1 (3.5) 1 (3.6) 4 (14.3)
Functional health literacy (n [%])*
  inadequate 6 (19.4) 5 (17.2) 1.0 14 (50.0) 11 (39.3) 0.37
  Marginal 20 (64.5) 20 (69.0) 11 (39.3) 10 (35.7)
  Adequate 5 (16.1) 4 (13.8) 3 (10.7) 7 (25.0)
spanish language  
administration (n [%])
n/A n/A 23 (82.1) 24 (85.7) 1.0
Notes: *Measured by the short Test of Functional health Literacy in Adults; P values are from t-tests (for age) or χ2 tests or Fisher’s exact tests for categorical variables.
Table 2 statin knowledge scores at pretest and post-test
n Pretest score  
(mean [SD])
Post-test score  
(mean [SD])
Difference P value
African American patients
  Audio booklet 31 8.39 [2.94] 10.87 [3.40] 2.48 [2.45] ,0.01
  standard of care 29 7.97 [2.67] 8.24 [2.61] 0.28 [2.19]
hispanic patients
  Audio booklet 28 4.82 [3.87] 6.21 [3.57] 1.39 [2.78] 0.03
  standard of care 28 7.21 [3.52] 7.00 [4.00] -0.21 [2.64]
Notes: Means are from sum of correct responses to 15-item knowledge measure. P values from t-test on difference scores.Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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the booklet had more knowledge about statins and were less 
likely to report having missed a dose after three months of 
the intervention.22 Our study is different in that it can also be 
used with patients who cannot read at all. Additionally, our 
intervention was available in English and Spanish.
We further found that before the intervention patients 
already appreciated the severity of their condition and con-
sidered themselves susceptible to heart attack and stroke. 
They similarly reported high self-efficacy and response 
efficacy before the intervention. Effective health messaging 
may have a role in reinforcing already positive appraisals of 
treating high cholesterol with statins, but additional gains 
may not be realized given these high baseline values.
Given the problems associated with patient adherence to 
statin medication therapy,4,6,23 we need new interventions to 
assist clinicians in better educating patients as to the impor-
tance of staying on statin therapy even if they feel fine and 
their cholesterol levels normalize.
While statin therapy is important, clinicians are frequently 
pressed for time and do not think that they have enough time 
available to counsel patients appropriately.24,25 The problem 
is compounded by the fact that it is often difficult to gauge a 
patient’s health literacy rapidly, so the patient education that 
a clinician does deliver may not be appropriately worded for 
the patient to comprehend well.18,26
Our intervention is unique in the fact that it is for low 
health literacy patients, but was designed in such a way 
that it delivers the content in a manner appropriate for any 
health literacy level. In addition, it does not rely on precious 
clinician-patient time to be delivered. The clinician supplies 
the audio booklet to the patient and is available for questions; 
however most of the educational burden is shifted off the 
clinician and onto the audio booklet. Moreover, the fact that 
it is available in both English and Spanish means that the tool 
is able to reach the majority of the US patient population.
The sequelae of disease related to hyperlipidemia are well 
documented and established.27 For appropriate patients, tak-
ing a statin medication can dramatically decrease their risk of 
stroke and/or heart attack.28 Future research needs to consider 
the impact of the intervention on subsequent adherence over 
a longer period of time. Three study subjects reported that 
they had stopped taking statins, but after the intervention they 
planned on resuming them. For these types of patients, and 
for those who are just starting statin therapy, the intervention 
needs to be tested to see if it actually improves their taking 
of their statin.
The main limitation of this study were that the patients 
were limited to one health care system. The results may not 
be generalizable to other patient populations. Additionally, 
increased knowledge about statin therapy may or may not 
influence patient adherence with the regime.
Conclusion
In this study of a novel audio booklet that educates patients 
about high cholesterol and statin therapy, the interven-
tion was liked by patients and increased their knowledge 
about statin therapy. Future trials will need to evaluate the 
impact on patient behavior and the durability of effect. The 
intention behind the audio booklet was to relieve some 
of the counseling burden that physicians experience on 
a daily basis. We have demonstrated that the booklet can 
be integrated into practice with positive patient experi-
ences and increases in knowledge and understanding of 
statins. A future version of the booklet will be available on 
the web as both an interactive version and a downloadable 
version (see http://www.chainonline.org).
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